🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Spain / NCT06729437
Recruiting Not applicable

Transcranial Direct Current Stimulation on Functionality and Pain in Individuals With Patellar Tendinopathy

NCT06729437 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2024-07-01
Last updated
2026-06-25

Condition(s) studied

Patellar Tendinopathy

Investigational drug(s) / intervention(s)

tDCS + Therapeutic eccentric exerciseSham tDCS + Therapeutic eccentric exercise

tDCS + Therapeutic eccentric exercise: A direct current of 1.5 mA will be applied for 20 minutes to the primary motor cortex (M1) during each session of eccentric exercises.

Sham tDCS + Therapeutic eccentric exercise: The current will be interrupted after 30 seconds.

Study summary

The aim of the present study is to investigate the effectiveness of transcranial direct current stimulation (tDCS) prior to a therapeutic eccentric exercise program on parameters related to pain and functionality in individuals with patellar tendinopathy. For this purpose, participants will be randomly divided into two groups: i) experimental group, receiving tDCS prior to a therapeutic exercise program; and ii) control group, receiving sham tDCS and a therapeutic exercise program. The interventions will last for 8 weeks. Additionally, four assessments will be conducted (baseline, week 4, week 8 and week 12). The variables studied are related to pain, functionality, muscle activity and strength, proprioception, and quality of life.

Eligibility

Sex
ALL
Min age
18 Years
Max age
50 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Age between 18 and 50 years. * Diagnosis of patellar tendinopathy (VISA-P score of 80 or lower). * Pain lasting more than 3 months. Exclusion Criteria: * Previous knee surgery. * Corticosteroid injection in the previous 6 weeks. * Systemic inflammatory, autoimmune, or rheumatic diseases. * Cognitive or behavioural issues that hinder comprehension and adherence to the intervention. * Any neurological disease. * Neoplastic disease. * Subjects presenting contraindications for tDCS (Thair et al., 2017), including: personal and family history of epilepsy, metallic implants in the head, implanted medication pump, pacemaker, recurrent headaches, skin conditions (psoriasis, eczema), or major head surgeries, pregnancy, heart diseases, and various medications (psychotropic or antihistamines). * Subjects must not have undergone pharmacological treatment or knee physical rehabilitation programs for a period of 1 year.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Faculty of Physiotherapy, University of Valencia Valencia Valencia Recruiting

More University of Valencia trials in Spain

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06729437 on ClinicalTrials.gov ↗ ← All trials in Spain